David Makanjuola

Medicine · Health Sciences

11h-index450citations54works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(8), COVID-19 Clinical Research Studies(7), Vasculitis and related conditions(7), Pregnancy and preeclampsia studies(5), COVID-19 and healthcare impacts(5)

Publications51 total

Therapeutic Resolution of Pulmonary Arterial Hypertension (PAH) Using Natural Products
Targets·2024· 2 citedOpen Access
Assessing the Rates of Complications in Patients with Membranous Nephropathy Treated with Cyclical Intravenous Cyclophosphamide and Oral Prednisolone: A Single-Centre Experience
Journal of the American Society of Nephrology·2024· 1 cited
Outcomes in Membranous Nephropathy Treated with Intravenous Cyclophosphamide and Oral Prednisolone (Modification of the Modified Ponticelli Regimen): A Single-Centre Experience
Journal of the American Society of Nephrology·2024
Rituximab in Addition to Plasma Exchange, Cyclophosphamide, and Steroids for the Treatment of Anti-glomerular Basement Membrane (GBM) Disease
Journal of the American Society of Nephrology·2024
Outcomes following Treatment with Bortezomib in Patients with Multiple Myeloma Who Required Haemodialysis: A Single-Centre Experience
Journal of the American Society of Nephrology·2024
Treatment outcomes of multiple myeloma in patients requiring renal replacement therapy
Journal of Renal Injury Prevention·2024Open Access
WCN24-725 BLOOD PRESSURE VARIATION DURING AVF/AVG THROMBECTOMY
Kidney International Reports·2024Open Access
Pregnancy outcomes for women with pre‐existing renal disease and the role of a dedicated joint maternal medicine and renal clinic: A retrospective cohort study
International Journal of Gynecology & Obstetrics·2024· 1 cited
Comparison of Two Scores for Renal ANCA-Associated Vasculitis (AAV) in Predicting Renal Outcomes
Journal of the American Society of Nephrology·2023
Proteinuria and Haematuria
2023
Effect of the COVID-19 Pandemic on Incidence of Glomerular Disease: A Single Centre Report
Journal of the American Society of Nephrology·2022· 1 cited
Effect of the COVID-19 Pandemic on Clinical Phenotype of Glomerular Disease: Single Centre Experience
Journal of the American Society of Nephrology·2022
Membranous Nephropathy in the Era of COVID-19 and Vaccines: Is There a Story to Tell?
Journal of the American Society of Nephrology·2022
Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study
Nephrology Dialysis Transplantation·2022· 19 citedOpen Access
Severity of COVID-19 after Vaccination among Hemodialysis Patients
Clinical Journal of the American Society of Nephrology·2022· 54 citedOpen Access
The 370-Da Inhibitor of the Sodium Pump in the Plasma of Haemodialysis Patients
Kidney & Blood Pressure Research·2021Open Access
Fludrocortisone Is an Effective Treatment for Hyperkalaemic Metabolic Acidosis in Kidney Transplant Recipients on Tacrolimus: A Case Series
˜The œNephron journals/Nephron journals·2021· 8 cited
Tackling the COVID-19 Pandemic- A Review
Journal of Bio-Science·2021Open Access
Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients
Clinical Journal of the American Society of Nephrology·2021· 40 citedOpen Access
POS-513 RISK OF COVID-19 DISEASE, DIALYSIS UNIT ATTRIBUTES AND INFECTION CONTROL STRATEGY AMONG LONDON IN-CENTRE HAEMODIALYSIS PATIENTS: A RETROSPECTIVE COHORT STUDY
Kidney International Reports·2021Open Access
page 1 of 3Next →

Frequent Co-authors

Bhrigu Sood(9), Nicholas Cole(8), Kate Bramham(7), Elham Asgari(6), Richard Hull(6), Alexander Sarnowski(5), Debasish Banerjee(5), Hassan Shehata(5), Damien Ashby(4), Ben Caplin(4), Kieran McCafferty(4), Hugh Cairns(4), Claire C. Sharpe(4), Martin L. Ford(4), Eirini Lioudaki(4), Mysore K. Phanish(4), Richard Corbett(3), Nicola Kumar(3), Alan D. Salama(3), Pauline A. Swift(3)